The European Investment Fund and ALTUM have launched a new cooperation supported by the EU’s InvestEU programme to improve ...
Simulating a billion years using previous best-resolution simulations would take almost 36 years of real computing time.
AstraZeneca’s Alexion division has received FDA approval for Koselugo (selumetinib) to treat adults with NF1 who have symptomatic, inoperable plexiform neurofibromas. The decision is based on strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback